← ANALYSTS · TIPRANKS
Les Sulewski · Oppenheimer
Hits
51%
65 of 128 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+11.5%
Over a year after the rating, TipRanks’ measure
Our companies rated now
7
Buy / hold / sell: 5 / 2 / 0
Upside of the analyst’s targets
+70.8%
Average over 6 current targets, to the last price
The market’s answer to the ratings
−4.1%
Day-0 move against SPY in the rating’s direction, average over 7 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 9on TipRanks Oct 12 05:50 | COLLIWMCollegium Pharmaceutical · $733M | Reiterated | Buy | $50.00 | +115.6% | −0.7%next day −0.1% · 5 days +6.9% | ↗ |
| Oct 8on TipRanks 13:30 | PCRXIWMPacira Pharmaceuticals · $1.4B | Downgrade | Hold | — | — | +44.8%next day −0.8% · 5 days +0.1% | ↗ |
| Sep 23on TipRanks Sep 30 05:50 | VNDAIWMVanda · $256M | Initiated | Buy | $10.00 | +148.1% | −2.5%next day −1.1% · 5 days −1.9% | ↗ |
| Sep 23on TipRanks Sep 30 02:55 | INVAIWMInnoviva · $1.5B | Initiated | Buy | $35.00 | +68.4% | −2.8%next day +2.2% · 5 days +5.5% | ↗ |
| Sep 23on TipRanks Sep 29 21:02 | AMRXIWMAmneal Pharmaceuticals · $6.1B | Initiated | Buy | $27.00 | +40.8% | −0.2%next day +2.5% · 5 days +4.9% | ↗ |
| Sep 23on TipRanks Sep 28 21:02 | ANIPIWMANI Pharmaceuticals · $1.7B | Initiated | Hold | $85.00 | +17.6% | −3.7%next day −0.4% · 5 days −1.7% | ↗ |
| Sep 23on TipRanks Sep 28 21:01 | PCRXIWMPacira Pharmaceuticals · $1.4B | Initiated | Buy | $32.00 | −11.9% | +0.4%next day +3.9% · 5 days +2.4% | ↗ |
| Sep 23on TipRanks Sep 25 00:05 | COLLIWMCollegium Pharmaceutical · $733M | Initiated | Buy | $50.00 | +115.6% | −0.7%next day +0.9% · 5 days −2.1% | ↗ |
| Sep 23on TipRanks 21:00 | VTRSSPYViatris · $20.9B | Initiated | Buy | $25.00 | +34.0% | +1.8%next day +1.8% · 5 days +0.6% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗